Business
Procrit (Amgen) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
Key market opportunities include addressing rising anemia prevalence, expanding biologic anemia therapies, increasing chronic disease treatment, emphasizing personalized anemia management, boosting biosimilar adoption, enhancing patient quality of life, and tapping into growing demand in Asia-Pacific. Tariff challenges are sparking domestic production and regional partnerships.Dublin, May 07, 2026 (GLOBE NEWSWIRE) -- The "Procrit Market Report 2026: Epidemiology, Pipeline Analysis, Market Insigh
About this update from Amgen Inc.
[{"type":"image","alt":"Company Logo","displaySize":"","headline":null,"caption":"Company Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":36,"url":"https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/LAb6sww2pvOwp1YOuMHMug--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUw/https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65","width":300,"height":36}},"lazy":false},{"type":"text","content":"Key market opportunities include addressing rising anemia prevalence, expanding biologic anemia therapies, increasing chronic disease treatment, emphasizing personalized anemia management, boosting biosimilar adoption, enhancing patient quality of life, and tapping into growing demand in Asia-Pacific. Tariff challenges are sparking domestic production and regional partnerships.","length":380,"tagName":"p"},{"type":"text","content":"Dublin, May 07, 2026 (GLOBE NEWSWIRE) -- The "Procrit Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering.","length":207,"tagName":"p"},{"type":"text","content":"The Procrit market is poised for substantial growth, driven by the increasing prevalence of anemia, chronic kidney disease (CKD), and cancer. A significant factor behind this trend is the rising adoption of biologic anemia therapies and improved access to prescription anemia drugs. As of the historic period, the market had been bolstered by factors such as the rising chemotherapy-induced anemia cases and the expansion of dialysis treatment centers.","length":452,"tagName":"p"},{"type":"text","content":"Looking ahead, the market is expected to benefit from a growing focus on personalized anemia management, increased use of erythropoiesis-stimulating agents, and the demand for anemia management therapies. The expansion of chronic disease treatment programs and oncology supportive care treatments will further drive market dynamics. Another crucial trend is the growing emphasis on reducing the need for blood transfusions, complemented by enhanced monitoring of chronic anemia conditions.","length":489,"tagName":"p"},{"type":"text","content":"Procrit (epoetin alfa) effectively addresses anemia by stimulating red blood cell production, providing an alternativ...